130 related articles for article (PubMed ID: 31520165)
1. QSPR Modeling of Biopharmaceutical Properties of Hydroxypropyl Methylcellulose (Cellulose Ethers) Tablets Based on Its Degree of Polymerization.
Kasabe AJ; Kulkarni AS; Gaikwad VL
AAPS PharmSciTech; 2019 Sep; 20(8):308. PubMed ID: 31520165
[TBL] [Abstract][Full Text] [Related]
2. Computational Modeling of Polymeric Physicochemical Properties for Formulation Development of a Drug Containing Basic Functionality.
Gaikwad VL; Bhatia NM; Singhvi I; Mahadik KR; Bhatia MS
J Pharm Sci; 2017 Nov; 106(11):3337-3345. PubMed ID: 28688842
[TBL] [Abstract][Full Text] [Related]
3. Drug release and swelling kinetics of directly compressed glipizide sustained-release matrices: establishment of level A IVIVC.
Sankalia JM; Sankalia MG; Mashru RC
J Control Release; 2008 Jul; 129(1):49-58. PubMed ID: 18456362
[TBL] [Abstract][Full Text] [Related]
4. Formulation and evaluation of diclofenac controlled release matrix tablets made of HPMC and Poloxamer 188 polymer: An assessment on mechanism of drug release.
Al-Hanbali OA; Hamed R; Arafat M; Bakkour Y; Al-Matubsi H; Mansour R; Al-Bataineh Y; Aldhoun M; Sarfraz M; Dardas AKY
Pak J Pharm Sci; 2018 Jan; 31(1(Suppl.)):345-351. PubMed ID: 29386164
[TBL] [Abstract][Full Text] [Related]
5. In vitro release of ketoprofen from hydrophilic matrix tablets containing cellulose polymer mixtures.
Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
Drug Dev Ind Pharm; 2013 Nov; 39(11):1651-62. PubMed ID: 23094867
[TBL] [Abstract][Full Text] [Related]
6. Formulation and optimization of floating matrix tablets of clarithromycin using simplex lattice design.
Singh I; Saini V
Pak J Pharm Sci; 2016 Mar; 29(2):511-9. PubMed ID: 27087096
[TBL] [Abstract][Full Text] [Related]
7. Design and in vitro evaluation of zidovudine oral controlled release tablets prepared using hydroxypropyl methylcellulose.
Ravi PR; Ganga S; Saha RN
Chem Pharm Bull (Tokyo); 2008 Apr; 56(4):518-24. PubMed ID: 18379101
[TBL] [Abstract][Full Text] [Related]
8. Development of controlled release tablet by optimizing HPMC: consideration of theoretical release and RSM.
Pani NR; Nath LK
Carbohydr Polym; 2014 Apr; 104():238-45. PubMed ID: 24607183
[TBL] [Abstract][Full Text] [Related]
9. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
[TBL] [Abstract][Full Text] [Related]
10. Mucoadhesive elementary osmotic pump tablets of trimetazidine for controlled drug delivery and reduced variability in oral bioavailability.
Alam N; Beg S; Rizwan M; Ahmad A; Ahmad FJ; Ali A; Aqil M
Drug Dev Ind Pharm; 2015 Apr; 41(4):692-702. PubMed ID: 24669975
[TBL] [Abstract][Full Text] [Related]
11. Novel extended in vitro-in vivo correlation model for the development of extended-release formulations for baclofen: From formulation composition to in vivo pharmacokinetics.
Kim TH; Bulitta JB; Kim DH; Shin S; Shin BS
Int J Pharm; 2019 Feb; 556():276-286. PubMed ID: 30543888
[TBL] [Abstract][Full Text] [Related]
12. Effect of formulation composition on the properties of controlled release tablets prepared by roller compaction.
Hariharan M; Wowchuk C; Nkansah P; Gupta VK
Drug Dev Ind Pharm; 2004 Jul; 30(6):565-72. PubMed ID: 15285329
[TBL] [Abstract][Full Text] [Related]
13. A formulation approach for development of HPMC-based sustained release tablets for tolterodine tartrate with a low release variation.
Cao QR; Choi JS; Liu Y; Xu WJ; Yang M; Lee BJ; Cui JH
Drug Dev Ind Pharm; 2013 Nov; 39(11):1720-30. PubMed ID: 23062115
[TBL] [Abstract][Full Text] [Related]
14. Formulation and evaluation of effervescent floating tablets of tizanidine hydrochloride.
Someshwar K; Chithaluru K; Ramarao T; Kumar KK
Acta Pharm; 2011 Jun; 61(2):217-26. PubMed ID: 21684848
[TBL] [Abstract][Full Text] [Related]
15. Effects of manufacturing process variables on in vitro dissolution characteristics of extended-release tablets formulated with hydroxypropyl methylcellulose.
Huang Y; Khanvilkar KH; Moore AD; Hilliard-Lott M
Drug Dev Ind Pharm; 2003 Jan; 29(1):79-88. PubMed ID: 12602495
[TBL] [Abstract][Full Text] [Related]
16. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
[TBL] [Abstract][Full Text] [Related]
17. Formulation and evaluation of dextromethorphan hydrobromide sustained release tablets.
Meyyanathan SN; Rajan S; Muralidaharan S; Siddaiah MK; Krishnaraj K; Suresh B
Drug Deliv; 2008 Sep; 15(7):429-35. PubMed ID: 18712620
[TBL] [Abstract][Full Text] [Related]
18. Hydroxypropyl methylcellulose based cephalexin extended release tablets: influence of tablet formulation, hardness and storage on in vitro release kinetics.
Saravanan M; Sri Nataraj K; Ganesh KS
Chem Pharm Bull (Tokyo); 2003 Aug; 51(8):978-83. PubMed ID: 12913240
[TBL] [Abstract][Full Text] [Related]
19. Experimental and chemoinformatics evaluation of some physicochemical properties of excipients influencing release kinetics of the acidic drug ibuprofen.
Gaikwad VL; Bhatia MS; Singhvi I
Chemosphere; 2015 Nov; 138():494-502. PubMed ID: 26197081
[TBL] [Abstract][Full Text] [Related]
20. Preparation and investigation of novel gastro-floating tablets with 3D extrusion-based printing.
Li Q; Guan X; Cui M; Zhu Z; Chen K; Wen H; Jia D; Hou J; Xu W; Yang X; Pan W
Int J Pharm; 2018 Jan; 535(1-2):325-332. PubMed ID: 29051121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
